Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is
responsible for the majority of cancer-related deaths worldwide. The management of …

Simple Summary Lung cancer is a widespread malignant tumour with a high mortality and
morbidity rate and is frequently diagnosed in the middle and late stages when few therapies …

Summary Background In Taiwan, lung cancers occur predominantly in never-smokers, of
whom nearly 60% have stage IV disease at diagnosis. We aimed to assess the efficacy of …

Background Characteristics of ground-glass nodules (GGNs) in Asian women who have
never smoked with family history of lung cancer (FHLC) remain unexamined. Purpose To …

As a lung cancer biomarker, exosomes were utilized for in vitro diagnosis to overcome the
lack of sensitivity of conventional imaging and the potential harm caused by tissue biopsy …

Compared to other malignancies, few studies have investigated the role of family history of
cancer (FHC) in patients with lung cancer, yielding largely heterogeneous results. We …

The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …

Worldwide, lung cancer is the most common killer among cancers, advanced disease has
worse outcomes, earlier stage detection leads to better outcomes, and high-quality …

Lung cancer (LC) is the leading cause of cancer-related deaths worldwide and the second
most common cancer in both men and women. In addition to smoking, other risk factors …

Introduction The role of a family history of lung cancer (LCFH) in screening using low-dose
computed tomography (LDCT) has not been prospectively investigated with long-term follow …